Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose bioequivalence study of generic lercanidipine vs ZANIDIP under fasting in healthy Thai volunteers
TCTR20230120003Phase 4Unknown
- Sponsor
- International Bio Service
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lercanidipine in hypertension (HTN), sponsored by International Bio Service. Status: unknown.
02
Drugs
lercanidipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on TCTR20230120003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230120003.